Primary abdominal cocoon syndrome manifesting with Chilaiditi syndrome and intestinal obstruction: A case report.
Ali TajaddiniMohammadmehdi FallahiHoda HaghshenasSoheila-Sadat NourmohammadiLeila GhahramaniReza ShahriariradPublished in: Clinical case reports (2023)
Encapsulating peritoneal sclerosis or abdominal cocoon syndrome (ACS) is an uncommon cause of intestinal obstructions associated with encapsulation of the small bowel by a fibro collagenous sac. Clinical presentations of ACS are unspecific and most patients are diagnosed intraoperatively. Moreover, Chilaiditi syndrome is another rare cause of bowel obstruction defined by interposition of colon and liver. There is no reported relation between these two conditions and surgical intervention is the suggested approach for severe bowel obstruction following them individually. We present a case with both conditions and describe our approach. A 47-year-old male presented with complaints of colic abdominal pain and distention, nausea and several attacks of bilious and nonbilious vomiting, anorexia, and constipation in the last 10 days before his admission. Laboratory data were normal and abdominal X-ray showed large dilation at the distal part of the bowel without air fluid level. The patient underwent explorative laparotomy and a mass-like lesion containing necrotic bowel and a whitish spleen accompanied by a complete anterior-rotated liver was found. The encapsulated bowel and the spleen were resected followed by the complete resolution of symptoms in the patient. The intestinal obstruction caused by ACS is mostly approached by surgery to prevent the fatal sequela of this condition.
Keyphrases
- case report
- acute coronary syndrome
- abdominal pain
- minimally invasive
- randomized controlled trial
- ejection fraction
- end stage renal disease
- emergency department
- high resolution
- magnetic resonance imaging
- computed tomography
- chronic kidney disease
- physical activity
- coronary artery bypass
- coronary artery disease
- machine learning
- patient reported outcomes
- early onset
- single molecule
- patient reported
- irritable bowel syndrome
- percutaneous coronary intervention